1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

Drugs for Urinary Incontinence and Overactive Bladder: Global Markets to 2022

  • March 2018
  • 179 pages
  • ID: 5370230

Summary

Table of Contents

Report Scope:
This research report categorizes the drugs for urinary incontinence and overactive bladder by type. Product type include Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity.

Report Includes:
- 96 data tables.
- An overview of the global market for drugs for urinary incontinence and overactive bladder
- Analyses of global market trends, with data from 2013 to 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Coverage of types of urinary incontinence such as urge incontinence (UUI), stress incontinence (SUI), overflow incontinence (OUI), functional incontinence (FUI), and mixed symptoms (MUI)
- Identification of effective treatment options for incontinence and overactive bladder
- Analyses of Idiopathic bladder overactivity and neurogenic bladder overactivity and their probable causes
- Detailed profiles of key competitors of the market, including Astellas Pharma Inc., Pfizer, Inc., Allergan, PLC., Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Limited and Ferring Pharmaceuticals A/S

Summary
Global urinary incontinence and overactive bladder market growth outlook is positive. with significant growth potential This disease is widely prevalent among the elderly and women population globally. At the same time, emerging markets growth, sedentary lifestyles, health insurance reforms, rising ageing population, technological advances aiding research and development activities, diagnosis and treatment is driving the demand of drugs for urinary incontinence and overactive bladder market.

The market for urinary incontinence and overactive bladder drugs is expected to be driven by advances in drug development. Mainly, site specific local drug delivery, lower side effects, different forms of medications and combination therapy are the major trends in the market.

The drugs for urinary incontinence and overactive bladder market reached a value of nearly REDACTED in 2017 and is expected to grow at a compound annual growth rate (CAGR) of REDACTED to nearly REDACTED by 2020.

The drugs for urinary incontinence and overactive bladder market is dominated by one large player, constituting for REDACTED.Major players in the market are Astellas, Pfizer, Allergan, Merck and others.

Idiopathic bladder overactivity accounted for the largest share of the drugs for urinary incontinence and overactive bladder market in 2017 at REDACTED. The highest growth is projected to also expected to come from the same segment, which is forecasted to grow at a CAGR of REDACTED.

Asia Pacific is the largest drugs for urinary incontinence and overactive bladder market, accounting for REDACTED of the global market.It was followed by North America and Western Europe region.

Going forward, Asia Pacific is expected to witness the fastest growth in the drugs for urinary incontinence and overactive bladder market, estimated at grow at a CAGR of REDACTED, followed by Africa, which is expected to grow at a CAGR of REDACTED.

The USA is the largest market in terms of value and in the drugs for urinary incontinence and overactive bladder market. China and India are forecasted to have the fastest growth, growing at a CAGR of REDACTED and REDACTED, respectively.

The market is challenged by restraints such as decline in patent expiration of drugs, increasing popularity of alternative treatments and therapies, social stigmas associated with the disease and lack of awareness among people in many countries globally.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Adult Diapers Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Adult Diapers Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • $ 4795
  • Industry report
  • July 2018
  • by Infinium

The report on global adult diapers market provides qualitative and quantitative analysis for the period of 2016 to 2024.The report predicts the global adult diapers market to grow with a CAGR of 7.2% ove ...

Super Absorbent Polymers Market Size, Share & Trends Analysis Report By Application, By Region And Segment Forecasts, 2012 - 2022

Super Absorbent Polymers Market Size, Share & Trends Analysis Report By Application, By Region And Segment Forecasts, 2012 - 2022

  • $ 4450
  • Industry report
  • July 2018
  • by Grand View Research

Super Absorbent Polymers Market Size, Share & Trends Analysis Report By Application (Agriculture, Baby Diapers, Adult Incontinence Products, Female Hygiene Products), By Region, And Segment Forecasts, ...

Stress Urinary Incontinence Global Clinical Trials Review, H2, 2018

Clinical Research in Stress Urinary Incontinence in H2, 2018

  • $ 2500
  • Industry report
  • August 2018
  • by GlobalData

Stress Urinary Incontinence Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Stress Urinary Incontinence Global Clinical Trials Review, H2, 2018" provides an overview ...


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on